Figs Inc
NYSE:FIGS
Figs Inc
NYSE:FIGS
Price:
14.97
USD
5.35%
Market Closed
Market Cap:
$2.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Figs Inc
NYSE:FIGS
|
US |
Relative Value
The Relative Value of one
FIGS
stock under the Base Case scenario is
7.63
USD.
Compared to the current market price of 14.97 USD,
Figs Inc
is
Overvalued by 49%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
FIGS
Relative Value
Base Case
7.63
USD
Overvaluation 49%
Multiples Across Competitors
FIGS Competitors Multiples
Figs Inc Competitors
Figs Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Figs Inc
NYSE:FIGS
|
2.4B USD | 3.9 | 72.5 | 46.8 | 57.9 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.2T JPY | 10.1 | 36.8 | 26.6 | 31.9 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
55.8B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.4B CHF | 3.5 | 37.2 | 14.3 | 27.9 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
96.2B DKK | 3.5 | 24.3 | 12.8 | 15.3 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.9B USD | 3.2 | 31.5 | 13.5 | 18.7 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 2.4 | 33.2 | 11.6 | 18.1 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
39.2B CNY | 8.3 | 22.9 | 20.6 | 20.6 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 1.1 | -15.5 | 16.8 | 54.5 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
36.8B CNY | 3.7 | 21.6 | 31.9 | 31.9 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
848.5B JPY | 6.5 | 48 | 22.6 | 30.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
